Recent 13F filings as of September 2025 show that 129 institutional investors hold a position in Solid Biosciences Inc. (NASDAQ:SLDB).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 30 Sep, 2025 | 11,833,539 | -73,107 | -0.61% | $73,012,936.00 |
| Bain Capital Life Sciences Investors, LLC | 30 Sep, 2025 | 7,911,669 | 0 | 0.00% | $48,814,998.00 |
| Siren, L.L.C. | 30 Sep, 2025 | 7,415,905 | 0 | 0.00% | $45,756,134.00 |
| RA CAPITAL MANAGEMENT, L.P. | 30 Sep, 2025 | 5,811,423 | 100 | 0.00% | $35,856,480.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 4,725,118 | -194,965 | -3.96% | $29,153,978.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 30 Sep, 2025 | 4,000,000 | -2,729,484 | -40.56% | $24,680,000.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 3,083,850 | -281,697 | -8.37% | $19,027,355.00 |
| Vestal Point Capital, LP | 30 Sep, 2025 | 2,975,000 | 1,470,000 | 97.67% | $18,355,750.00 |
| FMR LLC | 30 Sep, 2025 | 2,914,127 | -264,273 | -8.31% | $17,980,164.00 |
| CITADEL ADVISORS LLC | 30 Sep, 2025 | 2,592,697 | 706,814 | 37.48% | $15,996,940.00 |
| Redmile Group, LLC | 30 Sep, 2025 | 1,899,342 | -16,584 | -0.87% | $11,718,940.00 |
| Nantahala Capital Management, LLC | 30 Sep, 2025 | 1,699,258 | -4,078 | -0.24% | $10,484,422.00 |
| Alyeska Investment Group, L.P. | 30 Sep, 2025 | 1,682,805 | 41,984 | 2.56% | $10,382,906.00 |
| MPM BioImpact LLC | 30 Sep, 2025 | 1,634,569 | 0 | 0.00% | $10,085,291.00 |
| FRANKLIN RESOURCES INC | 30 Sep, 2025 | 1,599,232 | 59 | 0.00% | $9,867,261.00 |
| Point72 Asset Management, L.P. | 30 Sep, 2025 | 1,333,005 | 66,948 | 5.29% | $8,224,641.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 1,287,243 | -222,910 | -14.76% | $7,943,954.00 |
| STATE STREET CORP | 30 Sep, 2025 | 1,093,299 | 141,847 | 14.91% | $6,745,655.00 |
| Finepoint Capital LP | 30 Sep, 2025 | 961,251 | 0 | 0.00% | $5,930,919.00 |
| ARMISTICE CAPITAL, LLC | 30 Sep, 2025 | 936,000 | 536,000 | 134.00% | $5,775,120.00 |